Stocks

Why Evertz Technologies Limited stock is rising today

By Wealth Awesome Newsroom -
Stocks & ETFs:ET.TO
Photos provided by Pexels

Evertz Technologies Limited has seen a notable uptick in its stock price, closing up 2.86% in the last trading session.

Evertz Technologies Limited (ET.TO) experienced a positive trading day, with shares climbing to CA$17.27. This increase reflects investor confidence amid a backdrop of strategic corporate developments.

Investor takeaway: With the approval of a Normal Course Issuer Bid and a solid revenue report, Evertz is positioning itself for potential growth, making it a stock to watch for Canadian investors.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Evertz Technologies Limited

ET.TO

Full stock page โ†’

ET.TO

Evertz Technologies Limited

Source:WealthAwesomeWealthAwesome
โ†‘ $2.66 (18.49%)
120 day period
$14.29$16.70$19.10Jan 26Apr 22Jul 16

Market cap

$1.32B

P/E

21.1x

52W high

$21.27

52W low

$10.50

1W change

-4.37%

Beta

0.71

Analyst Price Targets

Based on analyst covering ET

๐Ÿ“ˆ

Wall Street analysts forecast ET stock price to rise 4.1% over the next 12 months.

Consensus

Neutral

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$17.75

+4.1% Upside

Current Price

C$17.05

Last close

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ET's historical volatility

HistoricalForecast68%95%
C$8.95C$14.07C$19.18C$24.29C$29.40C$34.52TodayMar 10May 13Jul 16Aug 28Oct 11Nov 23

30-Day Vol

53.9%

Annualized

90-Day Vol

33.4%

Annualized

Trend (90d)

+8.7%

Annualized drift

90d Mean

C$17.59

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$17.23C$14.30 โ€“ C$20.75
60 trading daysC$17.41C$13.38 โ€“ C$22.65
90 trading daysC$17.59C$12.74 โ€“ C$24.28

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Evertz Technologies Limited Closes at CA$17.27, Up 2.86%

With a market cap of CA$1.27 billion, Evertz's stock performance reflects growing investor interest and confidence in its strategic direction.

Bull case

The recent approval for a Normal Course Issuer Bid allows Evertz to buy back up to 3,774,227 common shares over the next year. This move could boost stock value and shows that management is confident in the company's future. Coupled with a reported revenue of CA$132.7 million, this suggests strong operational performance.

Bear case

Despite the positive movement, investors should stay cautious. The stock's intrinsic value is estimated at CA$18.83, indicating limited upside from its current price. Market volatility and sector challenges could also affect future performance.

Recent Developments Boost Investor Confidence

Evertz Technologies Limited recently received approval for a Normal Course Issuer Bid, allowing the company to buy back up to 3,774,227 common shares over the next year. This move is seen as a positive signal to investors, suggesting that the company's management believes in its future growth potential. Additionally, the reported Q2 revenue of CA$132.7 million highlights Evertz's strong performance in the communications sector, further bolstering investor sentiment.

Market Performance and Future Outlook

The stock's rise of 2.86% to CA$17.27 reflects growing interest among investors. With an estimated intrinsic value of CA$18.83, there is potential for further appreciation. However, investors should remain vigilant of market conditions and sector-specific challenges that could impact Evertz's performance moving forward. As the company navigates these dynamics, its strategic initiatives will be crucial in maintaining momentum.

Advertisement

Sponsored links

Advertisement